Debt-to-equity in % of Context Therapeutics Inc. from Q2 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Context Therapeutics Inc. quarterly Debt-to-equity history and change rate from Q2 2022 to Q3 2025.
  • Context Therapeutics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 4.53 %, a 14.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Context Therapeutics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 4.53 -0.76 -14.3% 30 Sep 2025
Q2 2025 3.38 -5.92 -63.6% 30 Jun 2025
Q1 2025 2.4 -21.8 -90.1% 31 Mar 2025
Q4 2024 3.31 -15.7 -82.6% 31 Dec 2024
Q3 2024 5.3 -8.68 -62.1% 30 Sep 2024
Q2 2024 9.3 -2.01 -17.8% 30 Jun 2024
Q1 2024 24.2 +14.8 +156% 31 Mar 2024
Q4 2023 19 +11.6 +155% 31 Dec 2023
Q3 2023 14 +7.21 +107% 30 Sep 2023
Q2 2023 11.3 +0.5 +4.62% 30 Jun 2023
Q1 2023 9.43 31 Mar 2023
Q4 2022 7.45 31 Dec 2022
Q3 2022 6.77 30 Sep 2022
Q2 2022 10.8 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.